Regioselective hydroxylation of steroid hormones by human cytochromes P450
Abstract
This article reviews in vitro metabolic activities [including Michaelis constants (Km), maximal velocities (Vmax) and Vmax/Km] and drug-steroid interactions [such as induction and cooperativity (activation)] of cytochromes P450 (P450 or CYP) in human tissues, including liver and adrenal gland, for 14 kinds of endogenous steroid compounds, including allopregnanolone, cholesterol, cortisol, cortisone, dehydroepiandrosterone, estradiol, estrone, pregnenolone, progesterone, testosterone and bile acids (cholic acid). First, we considered the drug-metabolizing P450s. 6β-Hydroxylation of many steroids, including cortisol, cortisone, progesterone and testosterone, was catalyzed primarily by CYP3A4. CYP1A2 and CYP3A4, respectively, are likely the major hepatic enzymes responsible for 2-/4-hydroxylation and 16α-hydroxylation of estradiol and estrone, steroids that can contribute to breast cancer risk. In contrast, CYP1A1 and CYP1B1 predominantly metabolized estrone and estradiol to 2- and 4-catechol estrogens, which are endogenous ultimate carcinogens if formed in the breast. Some metabolic activities of CYP3A4, including dehydroepiandrosterone 7β-/16α-hydroxylation, estrone 2-hydroxylation and testosterone 6β-hydroxylation, were higher than those for polymorphically expressed CYP3A5. Next, we considered typical steroidogenic P450s. CYP17A1, CYP19A1 and CYP27A1 catalyzed steroid synthesis, including hydroxylation at 17α, 19 and 27 positions, respectively. However, it was difficult to predict which hepatic drug-metabolizing P450 or steroidogenic P450 will be mainly responsible for metabolizing each steroid hormone in vivo based on these results. Further research is required on the metabolism of steroid hormones by various P450s and on prediction of their relative contributions to in vivo metabolism. The findings collected here provide fundamental and useful information on the metabolism of steroid compounds.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hepatic xenobiotic-metabolizing CYPs are able to modify steroid hormones and generate a plethora of minor steroid metabolites.
“Hepatic xenobiotic-metabolizing members of the CYP superfamily are able to modify steroid hormones and generate a plethora of minor steroid metabolites [116].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [116]
At least 17 hepatic CYPs potentially participate in the metabolism of steroids.
“with at least 17 hepatic CYPs potentially participating in the metabolism of steroids [[116], [117], [118]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [116]
CYP3A4 is the most abundant P450 in the liver and predominantly, though not exclusively, catalyses the 6β-hydroxylation of T and the 16α- and 7α-hydroxylation of DHEA.
“CYP3A4 is the most abundant P450 in the liver (∼30%) (Shimada et al., 1994) and predominantly, though not exclusively, catalyses the 6β-hydroxylation of T and the 16α- and 7α-hydroxylation of DHEA (Niwa et al., 2015).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Niwa et al., 2015
Prostate cells express CYP3A4 that can inactivate T by conversion to mainly 6βOH-T.
“Prostate cells also express CYP3A4 that can inactivate T by conversion to mainly 6βOH-T (with 2β-, 15α/β- and 11β-hydroxyl side product formation (Niwa et al., 2015))”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Niwa et al., 2015
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · see citing works
Rendić, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 1,165 · see citing works
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. T. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 964 · see citing works
Summary of information on human CYP enzymes: human P450 metabolism data
Rendić, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 819 · see citing works
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541 · see citing works
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.883 · Cited by 471 · see citing works
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 457 · see citing works
Developmental Expression of the Major Human Hepatic CYP3A Enzymes
Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J., & Zaya, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054841 · Cited by 368 · see citing works
Gillam, E. M. J., Baba, T., Kim, B., Ohmori, S., & Guengerich, F. P. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1401 · Cited by 340 · see citing works
Yamazaki, H., & Shimada, T. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0302 · Cited by 310 · see citing works
Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
Spink, D. C. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.291 · Cited by 310 · see citing works
Purification and characterization of human placental aromatase cytochrome P-450.
Kellis, J. T., & Vickery, L. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61364-x · Cited by 290 · see citing works
Catalytic properties of polymorphic human cytochrome P450 1B1 variants
Shimada, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1607 · Cited by 272 · see citing works
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
Russo, J., Lareef, M. H., Balogh, G., Guo, S., & Russo, I. H. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00390-x · Cited by 252 · see citing works
Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050245 · Cited by 239 · see citing works
Yamazaki, H., Nakamura, M., Komatsu, T., Ohyama, K., Hatanaka, N., Asahi, S., Shimada, N., Guengerich, F. P., Shimada, T., Nakajima, M., et al. (2002) · Protein Expression and Purification · doi:10.1006/prep.2001.1578 · Cited by 234 · see citing works
The role of cytochrome b5 in the biosynthesis of androgens by human P450c17
Katagiri, M., Kagawa, N., & Waterman, M. R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1173 · Cited by 223 · see citing works
Multiple forms of human P450 expressed in Saccharomyces cerevisiae
Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakaki, T., Yabusaki, Y., & Funae, Y. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00052-4 · Cited by 207 · see citing works
4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Diczfalusy, U., Nylén, H., Elander, P., & Bertilsson, L. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03773.x · Cited by 202 · see citing works
Badawi, A. F., Cavalieri, E. L., & Rogan, E. G. (2001) · Metabolism · doi:10.1053/meta.2001.25592 · Cited by 184 · see citing works
Yamazaki, H., Shaw, P. M., Guengerich, F. P., & Shimada, T. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970217f · Cited by 182 · see citing works
Flück, C. E., Miller, W. L., & Auchus, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030143 · Cited by 173 · see citing works
Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone
Choi, S.-Y., Koh, K. H., & Jeong, H. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046276 · Cited by 161 · see citing works
Kenworthy, K. E., Clarke, S. E., Andrews, J., & Houston, J. B. (2001) · PubMed · Cited by 160 · see citing works
Imai, T., Globerman, H., Gertner, J. M., Kagawa, N., & Waterman, M. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36570-6 · Cited by 153 · see citing works
Cytochrome P450s and cholesterol homeostasis
Pikuleva, I. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.014 · Cited by 153 · see citing works
Lee-Robichaud, P., Wright, J. N., Akhtar, M. E., & Akhtar, M. (1995) · Biochemical Journal · doi:10.1042/bj3080901 · Cited by 145 · see citing works
Diczfalusy, U., Kanebratt, K. P., Bredberg, E., Andersson, T. B., Böttiger, Y., & Bertilsson, L. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03309.x · Cited by 130 · see citing works
Kerlan, V., Dréano, Y., Bercovici, J. P., Beaune, P. H., Floch, H. H., & Berthou, F. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90068-t · Cited by 128 · see citing works
CHOLESTEROL-METABOLIZING CYTOCHROMES P450
Pikuleva, I. A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008789 · Cited by 128 · see citing works
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
Cribb, A. E., Knight, M. J., Dryer, D., Guernsey, J., Hender, K., Tesch, M., & Saleh, T. M. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0801 · Cited by 118 · see citing works
Cholesterol 25-hydroxylation activity of CYP3A
Honda, A., Miyazaki, T., Ikegami, T., Iwamoto, J., Maeda, T., Hirayama, T. T., Saito, Y., Teramoto, T., & Matsuzaki, Y. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014084 · Cited by 115 · see citing works
Masimirembwa, C. M., Otter, C. A., Berg, M., Jönsson, M., Leidvik, B., Jonsson, E., Johansson, T., Bäckman, A., Edlund, A., & Andersson, T. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15034-9 · Cited by 106 · see citing works
Cytochromes P450: Roles in Diseases
Pikuleva, I. A., & Waterman, M. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.431916 · Cited by 106 · see citing works
Steroid Regulation of Drug-Metabolizing Cytochromes P450
Monostory, K., & Dvořák, Z. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016854 · Cited by 105 · see citing works
Agrawal, V., Choi, J. H., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833e0cb5 · Cited by 104 · see citing works
Kinetic Analysis of the Three-step Steroid Aromatase Reaction of Human Cytochrome P450 19A1
Sohl, C. D., & Guengerich, F. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123711 · Cited by 103 · see citing works
Jansson, I., Stoilov, I., Sarfarazi, M., & Schenkman, J. B. (2001) · Pharmacogenetics · doi:10.1097/00008571-200112000-00007 · Cited by 101 · see citing works
Niwa, T., Yabusaki, Y., Honma, K., MATSUO, N., 龍田, 佳., Ishibashi, F., & KATAGIRI, M. (1998) · Xenobiotica · doi:10.1080/004982598239290 · Cited by 97 · see citing works
Progesterone Oxidation by Cytochrome P450 2D Isoforms in the Brain
Hiroi, T., Kishimoto, W., Chow, T., Imaoka, S., Igarashi, T., & Funae, Y. (2001) · Endocrinology · doi:10.1210/endo.142.9.8363 · Cited by 94 · see citing works
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1174 · Cited by 91 · see citing works
Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain
Kishimoto, W., Hiroi, T., Shiraishi, M., Osada, M., Imaoka, S., Kominami, S., Igarashi, T., & Funae, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1109 · Cited by 90 · see citing works
Mulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88 · see citing works
Usmani, K. A., Cho, T. M., Rose, R. L., & Hodgson, E. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010439 · Cited by 83 · see citing works
Wu, D. A., & Chung, B. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115334 · Cited by 80 · see citing works
Thomas, J. L., Duax, W. L., Addlagatta, A., Brandt, S., Fuller, R. R., & Norris, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304752200 · Cited by 77 · see citing works
Yamazaki, H., Niwa, T., Murayama, N., & Emoto, C. (2008) · Current Drug Metabolism · doi:10.2174/138920008783331121 · Cited by 75 · see citing works
Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells
Lu, F., Zahid, M., SAEED, M. K., Cavalieri, E. L., & Rogan, E. G. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.102 · Cited by 74 · see citing works
Peng, C.-C., Templeton, I. E., Thummel, K. E., Davis, C. N., Kunze, K. L., & Isoherranen, N. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.53 · Cited by 73 · see citing works
Miller, K. K. M., Cai, J., Ripp, S. L., Pierce, W. M., Rushmore, T. H., & Prough, R. A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.305 · Cited by 73 · see citing works
Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
Nakamura, H., Nakasa, H., Ishii, I., Ariyoshi, N., Igarashi, T., Ohmori, S., & Kitada, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.534 · Cited by 70 · see citing works
Choi, M. H., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003327 · Cited by 69 · see citing works
Papageorgiou, I. S., Grepper, S., & Unadkat, J. D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049015 · Cited by 67 · see citing works
Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis
Shackleton, C. H. L. (2012) · Lipids · doi:10.1007/s11745-011-3605-6 · Cited by 61 · see citing works
Heterotropic Cooperativity in Oxidation Mediated by Cytochrome P450
Niwa, T., Murayama, N., & Yamazaki, H. (2008) · Current Drug Metabolism · doi:10.2174/138920008784746364 · Cited by 60 · see citing works
Miyazaki, M., Nakamura, K., Fujita, Y., Guengerich, F. P., Horiuchi, R., & Yamamoto, K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021816 · Cited by 60 · see citing works
Characterization of stable human aromatase expressed in E. coli
Kagawa, N., Hori, H., Waterman, M. R., & Yoshioka, S. (2004) · Steroids · doi:10.1016/j.steroids.2004.01.002 · Cited by 59 · see citing works
Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes
Rendić, S., Nolteernsting, E., & Schänzer, W. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00400-4 · Cited by 54 · see citing works
Role of cytochrome P450 in estradiol metabolism in vitro.
Cheng, Z., Shu, Y., Liu, Z., Wang, L., Ouyang, D., & Zhou, H.-H. (2001) · PubMed · Cited by 54 · see citing works
Mäenpää, J., Pelkonen, O., Cresteil, T., & Rane, A. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90152-m · Cited by 53 · see citing works
Schwarz, D., Kisselev, P., Schunck, W., Chernogolov, A. A., Boidol, W., Cascorbi, I., & Roots, I. (2000) · Pharmacogenetics · doi:10.1097/00008571-200008000-00005 · Cited by 53 · see citing works
Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor
Köhalmy, K., Tamási, V., Kob́ori, L., Sárváry, E., Pascussi, J., Porrogi, P., Rozman, D., Prough, R. A., Meyer, U., & Monostory, K. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016303 · Cited by 53 · see citing works
Deo, A. K., & Bandiera, S. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022194 · Cited by 53 · see citing works
Lee, A. J., Conney, A. H., & Zhu, B. T. (2003) · PubMed · Cited by 49 · see citing works
Niwa, T., Hiroi, T., Tsuzuki, D., Yamamoto, S., Narimatsu, S., Fukuda, T., Azuma, J., & Funae, Y. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.030 · Cited by 45 · see citing works
Oxidation of Endobiotics Mediated by Xenobiotic-Metabolizing Forms of Human Cytochrome P450
Niwa, T., Murayama, N., & Yamazaki, H. (2009) · Current Drug Metabolism · doi:10.2174/138920009789895525 · Cited by 45 · see citing works
Nakamura, H., Torimoto, N., Ishii, I., Ariyoshi, N., Nakasa, H., Ohmori, S., & Kitada, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.432 · Cited by 44 · see citing works
Diversity and Substrate Specificity in the Structures of Steroidogenic Cytochrome P450 Enzymes
Sugimoto, H., & Shiro, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.818 · Cited by 42 · see citing works
Niwa, T., Okada, K., Hiroi, T., Imaoka, S., Narimatsu, S., & Funae, Y. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.348 · Cited by 40 · see citing works
Niwa, T., Shiraga, T., Yamasaki, S., Ishibashi, K., Ohno, Y., & Kagayama, A. (2003) · Xenobiotica · doi:10.1080/0049825031000121617 · Cited by 39 · see citing works
Oxidation of Dihydrotestosterone by Human Cytochromes P450 19A1 and 3A4
Cheng, Q., Sohl, C. D., Yoshimoto, F. K., & Guengerich, F. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390047 · Cited by 38 · see citing works
Inhibition of Human Cytochrome P450 3A4 by Cholesterol
Shinkyo, R., & Guengerich, F. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240457 · Cited by 33 · see citing works
Swinney, D. C. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08683-0 · Cited by 31 · see citing works
16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Storbeck, K., Swart, P., Africander, D., Conradie, R., Toit, R. L.-D., & Swart, A. C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.016 · Cited by 28 · see citing works
Niwa, T., Murayama, N., & Yamazaki, H. (2011) · Current Drug Metabolism · doi:10.2174/138920011795495286 · Cited by 28 · see citing works
Ohmori, S., Fujiki, N., Nakasa, H., Nakamura, H., Ishii, I., Itahashi, K., & Kitada, M. (1998) · PubMed · Cited by 27 · see citing works
Interaction of CYP11B1 (cytochrome P‐45011β) with CYP11A1 (cytochrome P‐450scc) in COS‐1 cells
Cao, P., & Bernhardt, R. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00414.x · Cited by 26 · see citing works
A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio
Paracchini, V., Pedotti, P., Raimondi, S., GARTE, S. J., Bradlow, H. L., Sepkovic, D. W., & Taioli, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.119 · Cited by 25 · see citing works
Niwa, T., & Yamazaki, H. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850092 · Cited by 24 · see citing works
Shet, M. S., Fisher, C., Tremblay, Y., Bélanger, A., Conley, A. J., Mason, J. I., & Estabrook, R. W. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701468391 · Cited by 21 · see citing works
Lee, S., & Goldstein, J. A. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-sh-030 · Cited by 20 · see citing works
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterol
Diczfalusy, U., & Ingemar Björkhem, E. B. (2011) · Journal of Lipid Research · doi:10.1194/jlr.e017806 · Cited by 20 · see citing works
Comparison of Catalytic Properties of Cytochromes P450 3A4 and 3A5 by Molecular Docking Simulation
Niwa, T., Yasumura, M., Murayama, N., & Yamazaki, H. (2013) · Drug Metabolism Letters · doi:10.2174/1872312807666131229121228 · Cited by 18 · see citing works
Amino Acid Residues Affecting the Activities of Human Cytochrome P450 2C9 and 2C19
Niwa, T., Kageyama, A., Kishimoto, K., Yabusaki, Y., Ishibashi, F., & Katagiri, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.931 · Cited by 16 · see citing works
New Aspects on Primary Aldosteronism
Enberg, U., Volpe, C., & Hamberger, B. (2003) · Neurochemical Research · doi:10.1023/a:1022341619943 · Cited by 15 · see citing works
Niwa, T., Murayama, N., & Yamazaki, H. (2010) · Eisei kagaku · doi:10.1248/jhs.56.239 · Cited by 12 · see citing works
Rais, N., Hussain, A., Chawla, Y. K., & Kohli, K. K. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.842 · Cited by 10 · see citing works
Niwa, T., Imamura, H., & Katagiri, M. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00080 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450 · see citing works
“2, hepatic xenobiotic-metabolizing members of the CYP superfamily are able to modify steroid hormones and generate a plethora of minor steroid metabolites [116].”
Sex‐specificity in lung cancer risk
Stapelfeld, C., Dammann, C., & Maser, E. (2019) · International Journal of Cancer · doi:10.1002/ijc.32716 · Cited by 225 · see citing works
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217 · see citing works
“Prostate cells also express CYP3A4 that can inactivate T by conversion to mainly 6bOH-T (with 2b-, 15a/b- and 11b-hydroxyl side product formation (Niwa et al., 2015)) and a decrease of CYP3A4 expression is observed in prostate cancer (Fujimura et al.”
Arzuaga, X., Smith, M. T., Gibbons, C. F., Skakkebæk, N. E., Yost, E. E., Beverly, B., Hotchkiss, A. K., Hauser, R. B., de Souza, R. P., Schrader, S. M., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp5045 · Cited by 88 · see citing works
Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?
Charni‐Natan, M., Aloni-Grinstein, R., Osher, E., & Rotter, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00374 · Cited by 88 · see citing works
Rendić, S., & Guengerich, F. P. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02971-4 · Cited by 85 · see citing works
Arana‐Peña, S., Carballares, D., Berenguer‐Murcia, Á., Alcántara, A. R., Rodrigues, R. C., & Fernández‐Lafuente, R. (2020) · Catalysts · doi:10.3390/catal10060605 · Cited by 80 · see citing works
Chen, W.-Y., Fisher, M. J., Leung, A., Cao, Y., & Wong, L. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c02077 · Cited by 69 · see citing works
Jozwik, I. K., Kiss, F. M., Gricman, Ł., Abdulmughni, A., Brill, E., Zapp, J., Pleiss, J., Bernhardt, R., & Thunnissen, A. M. W. H. (2016) · FEBS Journal · doi:10.1111/febs.13911 · Cited by 60 · see citing works
Natural Products That Target Cancer Stem Cells.
Moselhy, J., Srinivasan, S., Ankem, M. K., & Damodaran, C. (2015) · PubMed · Cited by 57 · see citing works
Borrell, M., Gil‐Caballero, S., Bietti, M., & Costas, M. (2020) · ACS Catalysis · doi:10.1021/acscatal.9b05423 · Cited by 57 · see citing works
CYP1B1 as a therapeutic target in cardio-oncology
Carrera, A. N., Grant, M. K. O., & Zordoky, B. N. M. (2020) · Clinical Science · doi:10.1042/cs20200310 · Cited by 44 · see citing works
Liu, Z., Huang, J., Gu, Y., Clark, D. S., Mukhopadhyay, A., Keasling, J. D., & Hartwig, J. F. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10975 · Cited by 44 · see citing works
Toselli, F., Dodd, P. R., & Gillam, E. M. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1221960 · Cited by 36 · see citing works
de Rond, T., Gao, J., Zargar, A., de Raad, M., Cunha, J., Northen, T. R., & Keasling, J. D. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901782 · Cited by 36 · see citing works
Zheng, R., Shen, H., Li, J., Zhao, J., Lu, L., Hu, M., Lin, Z., Ma, H., Tan, H., Hu, M., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115824 · Cited by 35 · see citing works
Stucki, D., Krahl, H., Walter, M., Steinhausen, J., Hommel, K., Brenneisen, P., & Stahl, W. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108383 · Cited by 35 · see citing works
Huang, K., Cai, H., Bao, J., & Wu, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101132 · Cited by 36 · see citing works
Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences
Jourová, L., Vavrečková, M., Zemanová, N., Anzenbacher, P., Langová, K., Hermanová, P. P., Hudcovic, T., & Anzenbacherová, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01303 · Cited by 33 · see citing works
The consequence and mechanism of dietary flavonoids on androgen profiles and disorders amelioration
Hu, X., Li, X., Deng, P., Zhang, Y., Liu, R., Cai, D., Xu, Q., Jiang, X., Sun, J., & Bai, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2090893 · Cited by 32 · see citing works
Selective Hydroxylation of C(sp3)−H Bonds in Steroids
Abas, H., Blencowe, P., Brookfield, J. L., & Harwood, L. A. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202301066 · Cited by 31 · see citing works
Khatri, Y., Ringle, M., Lisurek, M., von Kries, J. P., Zapp, J., & Bernhardt, R. (2015) · ChemBioChem · doi:10.1002/cbic.201500420 · Cited by 31 · see citing works
Genotoxicity of ortho-quinones: reactive oxygen species versus covalent modification
Penning, T. M. (2017) · Toxicology Research · doi:10.1039/c7tx00223h · Cited by 29 · see citing works
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies
Niwa, T., Okamoto, A., Narita, K., Toyota, M., Kato, K., Kobayashi, K., & Sasaki, S. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108283 · Cited by 28 · see citing works
Niwa, T., Morimoto, M., Hirai, T., Hata, T., Hayashi, M., & Imagawa, Y. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.143 · Cited by 28 · see citing works
Wu, J.-J., Cao, Y., Feng, L., He, Y., Hong, J. Y., Dou, T., Wang, P., Hao, D., Ge, G., & Yang, L. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00001 · Cited by 28 · see citing works
Zhang, J., Gao, L.-Z., Chen, Y.-J., Zhu, P.-P., Yin, S.-S., Su, M., Ni, Y., Miao, J., Wu, W.-L., Chen, H., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.085670 · Cited by 28 · see citing works
Uehara, S., Uno, Y., Nakanishi, K., Ishii, S., Inoue, T., Sasaki, E., & Yamazaki, H. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074898 · Cited by 26 · see citing works
Mascia, F., Pereira, S. B., Pacheco, C. C., Oliveira, P., Solarczek, J., Schallmey, A., Kourist, R., Alphand, V., & Tamagnini, P. (2022) · Green Chemistry · doi:10.1039/d1gc04714k · Cited by 24 · see citing works
Xu, X., Bai, G., Song, L., Zheng, Q., Yao, Y., Liu, S., & Yao, C. (2017) · Electrochimica Acta · doi:10.1016/j.electacta.2017.11.195 · Cited by 24 · see citing works
Xu, X., Zheng, Q., Bai, G., Dai, Q., Cao, X., Yao, Y., Liu, S., & Yao, C. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.08.009 · Cited by 24 · see citing works
Bromek, E., & Daniel, W. A. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1872543 · Cited by 24 · see citing works
Zhu, R., Liu, Y., Yang, Y., Min, Q., Li, H., & Chen, L. (2022) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202200210 · Cited by 23 · see citing works
Liang, Z., Jiao, W., Wang, L., Chen, Y., Li, D., Zhang, Z., Zhang, Z., Liang, Y., & Niu, H. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113279 · Cited by 22 · see citing works
Chen, Y., Zhang, J., Zhu, P.-P., Xian-wen, T., Lin, Q.-H., Wang, W., Yin, S.-S., Gao, L.-Z., Su, M., Liu, C., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086637 · Cited by 21 · see citing works
A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson’s disease
Hartz, P., Fehlmann, T., Wagenpfeil, G., Unger, M. M., & Bernhardt, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1094265 · Cited by 21 · see citing works
Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5
Niwa, T., Narita, K., Okamoto, A., Murayama, N., & Yamazaki, H. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30558 · Cited by 21 · see citing works
Steroids hydroxylation catalyzed by the monooxygenase mutant 139-3 from Bacillus megaterium BM3
Liu, X., & Kong, J. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.04.006 · Cited by 20 · see citing works
Effects of xenobiotics on CYP1 enzyme-mediated biotransformation and bioactivation of estradiol
Mao, X., Li, H., & Zheng, J. (2023) · Drug Metabolism Reviews · doi:10.1080/03602532.2023.2177671 · Cited by 20 · see citing works
Villeneuve, D. L., Blackwell, B. R., Cavallin, J. E., Cheng, W., Feifarek, D. J., Jensen, K. M., Kahl, M. W., Milsk, R. Y., Poole, S. T., Randolph, E. C., et al. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4968 · Cited by 20 · see citing works
AhR governs lipid metabolism: the role of gut microbiota
Zheng, W., Liu, M., Lv, X., He, C., Yin, J., & Ma, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1442282 · Cited by 21 · see citing works
Dai, Q., Yang, L., Wang, Y., Cao, X., Yao, C., & Xu, X. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02727-0 · Cited by 19 · see citing works
Wang, Q., Ma, B., Fushinobu, S., Zhang, C., & Xu, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.091 · Cited by 18 · see citing works
Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9
Sun, D., Lu, J., Zhang, Y., Liu, J., Liu, Z., Yao, B., Guo, Y., & Wang, X. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000403 · Cited by 18 · see citing works
Marie, S., Frost, K. L., Hau, R. K., Martinez-Guerrero, L., Izu, J. M., Myers, C. M., Wright, S. H., & Cherrington, N. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.018 · Cited by 18 · see citing works
Structure–function analysis for the hydroxylation of Δ4 C21‐steroids by the myxobacterial CYP260B1
Salamanca-Pinzon, S. G., Khatri, Y., Carius, Y., Keller, L., Müller, R., Lancaster, C. R. D., & Bernhardt, R. (2016) · FEBS Letters · doi:10.1002/1873-3468.12217 · Cited by 18 · see citing works
Adachi, K., Ohyama, K., Tanaka, Y., Sato, T., Murayama, N., Shimizu, M., Saito, Y., & Yamazaki, H. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100486 · Cited by 17 · see citing works
Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism
Quinney, S. K., Benjamin, T. D., Zheng, X., & Patil, A. S. (2017) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2017.1354411 · Cited by 16 · see citing works
Niwa, T., & Hata, T. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.007 · Cited by 15 · see citing works
Niwa, T., Shizuku, M., & Yamano, K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.009 · Cited by 15 · see citing works
Arabnezhad, M., Montazeri‐Najafabady, N., Chatrabnous, N., Ghaffarian‐Bahraman, A., & Mohammadi‐Bardbori, A. (2019) · Steroids · doi:10.1016/j.steroids.2019.108508 · Cited by 15 · see citing works
Perreault, M., Maltais, R., Dutour, R., & Poirier, D. (2016) · Steroids · doi:10.1016/j.steroids.2016.08.015 · Cited by 15 · see citing works
Novel regulation of the transcription factor ZHX2 by N-terminal methylation
Conner, M. M., Parker, H. V., Falcone, D. R., Chung, G., & Tooley, C. E. S. (2022) · Transcription · doi:10.1080/21541264.2022.2079184 · Cited by 14 · see citing works
Goh, J. J. N., Behn, J., Chong, C., Zhong, G., Maurer‐Stroh, S., Fan, H., & Loo, L. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03111-2 · Cited by 13 · see citing works
Novel Cytochrome P450 2C94 Functionally Metabolizes Diclofenac and Omeprazole in Dogs
Uno, Y., Morikuni, S., Shiraishi, M., Asano, A., Murayama, N., & Yamazaki, H. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001236 · Cited by 13 · see citing works
Mao, Y., 中国科学院神经科学研究所神经科学国家重点实验室, 脑., Li, Y., Yang, Z., Xu, N., Zhang, S., Wang, X., Yang, X., Sun, Q., Mao, Y., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.322 · Cited by 12 · see citing works
Ye, X., Peng, T., Li, Y., Huang, T., Wang, H., & Hu, Z. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.106025 · Cited by 13 · see citing works
Kuhn, M. J., Mavangira, V., & Sordillo, L. M. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-18997 · Cited by 14 · see citing works
Saba, N., & Seal, A. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3611-1 · Cited by 11 · see citing works
Ma, W., Dang, D. X., Zhang, J., Wang, C., & Li, D. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13714 · Cited by 11 · see citing works
CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer
Aiyappa‐Maudsley, R., Storr, S. J., Rakha, E. A., Green, A. R., Ellis, I. O., & Martin, S. G. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.291 · Cited by 11 · see citing works
Effects of Shengmai San on key enzymes involved in hepatic and intestinal drug metabolism in rats
Chiang, T.-Y., Wang, H.-J., Wang, Y.-C., Tan, E. C., Lee, I., Yun, C., & Ueng, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113914 · Cited by 11 · see citing works
Li, J., Tang, Y., Li, W., & Tu, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905272 · Cited by 11 · see citing works
Pardhe, B. D., Kwon, K. P., Park, J. K., Lee, J. H., & Oh, T. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01585-22 · Cited by 11 · see citing works
A patent review of CYP3A4 inhibitors (2018 – present)
Tu, D., Hu, X., Lei, J.-X., Liu, S., Xiao, Z.-P., Yang, L., & Ge, G. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2470294 · Cited by 10 · see citing works
Gjorgoska, M., & Rižner, T. L. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101302 · Cited by 9 · see citing works
Niwa, T., & Imagawa, Y. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j31s53 · Cited by 9 · see citing works
Wang, J., Li, K., Zhang, X., Teng, D., Ju, M., Jing, Y., Zhao, Y., & Li, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-02698-w · Cited by 9 · see citing works
de Rond, T., Gao, J., Zargar, A., de Raad, M., Cunha, J., Northen, T. R., & Keasling, J. D. (2019) · Angewandte Chemie · doi:10.1002/ange.201901782 · Cited by 9 · see citing works
Fitch, W. L., Smith, S. M., Saporito, M. S., Busse, G., Zhang, M., Ren, J., Fitzsimmons, M. E., Yi, P. C., English, S., Carter, A. N., et al. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001218 · Cited by 9 · see citing works
Mo, H.-Y., Wei, Q.-Y., Zhong, Q.-H., Zhao, X.-Y., Guo, D., Han, J., Noracharttiyapot, W., Visser, L., van den Berg, A., Xu, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147853 · Cited by 8 · see citing works
Hummel, K., Gupta, S., Silva, A. M., Garcia, S. P., Odhiambo, D. H., Sygit, D., Cai, J., Ward, C. L., Kocarek, T. A., Sokolov, A. Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11695 · Cited by 7 · see citing works
Zhang, Y., Chen, Y., Dai, B., Bai, M., Lu, S., Lin, N., Zhou, H., & Jiang, H. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000685 · Cited by 7 · see citing works
Niwa, T., & Sugimoto, S. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30622 · Cited by 7 · see citing works
Цейликман, В. Э., Manukhina, E. B., Downey, H. F., Tseilikman, O. B., Misharina, M. E., Nikitina, A. A., Komelkova, M. V., Lapshin, M. S., Kondashevskaya, М. V., Lazuko, S. S., et al. (2016) · General Physiology and Biophysics · doi:10.4149/gpb_2015039 · Cited by 7 · see citing works
Su, W.-Y., Meng, W., Kong, L.-N., Chang, S., Zhang, J., Chang, Y., & Sun, Z. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102137 · Cited by 6 · see citing works
Huang, S., Xu, Y., Guo, Y., Zhang, Y., Tang, Y. C., Liang, C., Gao, L., Yao, B., & Wang, X. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116561 · Cited by 6 · see citing works
Shrivastava, P., Mondal, S., Thakur, S., Manhas, A., & Mehra, R. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00387 · Cited by 6 · see citing works
Niwa, T., Toyota, M., Kawasaki, H., Ishii, R., & Sasaki, S. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00987 · Cited by 6 · see citing works
Wang, C., Cheng, B., Wei, W., Gui, L., Zeng, W., Wang, Y., Wang, Y., Chen, Q., Xu, L., Miao, J., et al. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001513 · Cited by 5 · see citing works
Study specificity of isatin interactions with P450 cytochromes
Ershov, P. V., Mezentsev, Y. V., Yablokov, E. O., Kalushskiy, L. A., Florinskaya, A. V., Svirid, A. V., Gilep, A. A., Usanov, S. A., Medvedev, A. E., & Ivanov, A. S. (2018) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20186401061 · Cited by 5 · see citing works
Kalimuthu, P., Wojtkiewicz, A. M., Szaleniec, M., & Bernhardt, P. V. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201800616 · Cited by 5 · see citing works
Mechanistic considerations for reduced endometrial cancer risk by smoking
van den Berg, M., & van Duursen, M. B. M. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.09.002 · Cited by 5 · see citing works
SFC‐MS/MS for orthogonal separation of hydroxylated 17α‐methyltestosterone isomers
Bredendiek, F., & Parr, M. K. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3620 · Cited by 5 · see citing works
Specificity of Isatin Interaction with Cytochromes P450
Ershov, P. V., Mezentsev, Y. V., Yablokov, E. O., Kaluzhskiy, L. A., Florinskaya, A. V., Svirid, A. V., Gilep, A. A., Usanov, S. A., Medvedev, A. E., & Ivanov, A. S. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750818020026 · Cited by 4 · see citing works
Awareness and acceptance of hepatitis B vaccination in Clementi, Singapore.
Fong, N. P., Basir, H., & Seow, A. (1990) · PubMed · Cited by 4 · see citing works
Niwa, T., Tani, M., Suzuki, A., & Murakami, M. (2023) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681016666230830125358 · Cited by 3 · see citing works
Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation
Niwa, T., Sasaki, S., Yamamoto, Y., & Tanaka, M. (2022) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-022-00784-7 · Cited by 3 · see citing works
Matáková, T., Halasova, E., Dzian, A., Hruby, R., Halaša, M., Javorka, K., & Škereňová, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_220 · Cited by 3 · see citing works
Niwa, T., Arima, J., & Michihiro, Y. (2021) · Xenobiotica · doi:10.1080/00498254.2021.1989520 · Cited by 3 · see citing works
Pukło, R., Bromek, E., Basińska-Ziobroń, A., Haduch, A., Kuban, W., Danek, P. J., & Daniel, W. A. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100143 · Cited by 2 · see citing works
Covalent inhibitors of human cytochrome P450 3A4: research advances and future perspectives
Tu, D., Xiao, Z.-P., Liu, S., Hu, X., Lei, J.-X., Gong, J.-H., Zhang, F., Ding, X., Dai, Z., Zheng, J., et al. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217028 · Cited by 2 · see citing works
Mechanism-Based Inhibition of CYP3A Subfamilies by Macrolide Antibiotics and Piperine
Niwa, T., & Ishii, R. (2022) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681015666220804103005 · Cited by 2 · see citing works
Subedi, P., Do, H., Lee, J. H., & Oh, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113317 · Cited by 2 · see citing works
Zhang, S., Wang, T., Feng, Y., Li, F., Qu, A., Guan, X., Wang, H., & Xu, D. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.07.013 · Cited by 2 · see citing works
Kong, L., Abudula, A., Cong, J., Meng, W., Chang, Y., & Sun, Z. (2025) · Aquaculture International · doi:10.1007/s10499-025-01862-8 · Cited by 2 · see citing works
Kazakova, O. A., & Dolgikh, О. V. (2021) · Russian Journal of Immunology · doi:10.46235/1028-7221-243-pri · Cited by 2 · see citing works
Chang, K., Jiang, Z., Liu, C., Ren, J., Wang, T., & Xiong, J. (2016) · Medicine · doi:10.1097/md.0000000000004954 · Cited by 2 · see citing works
Bhatia, K. S., Mahesh, A. N., & Bhatt, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00696-5 · Cited by 2 · see citing works
Molecular plasticity contributes to thermal resilience in two coastal fish speciesPreprint
Riordan, B., Dutoit, L., King, T. M., Beheregaray, L. B., Gemmell, N. J., Hickey, A. J., & Johnson, S. L. (2024) · doi:10.32942/x2hp6f · Cited by 2 · see citing works
- Authors
- Niwa, T., Murayama, N., Imagawa, Y., & Yamazaki, H.
- Affiliations
- Shujitsu University (JP)
- Showa Pharmaceutical University (JP)
- Corresponding author
- Yamazaki, Hiroshi
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2015-02-13
- Volume
- 47
- Issue
- 2
- Pages
- 89-110
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2041685866
- Cited by
- 121
- References
- 88
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 7 · 2023: 12 · 2022: 18 · 2021: 10 · 2020: 13 · 2019: 14 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Steroid Chemistry and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Keywords
- steroid hormone metabolism, cytochrome P450, regioselective hydroxylation, CYP3A4, CYP1A2, CYP1A1, CYP1B1, CYP17A1, CYP19A1, CYP27A1, CYP3A5, enzyme induction, cooperativity, estradiol, estrone, catechol estrogens, breast cancer risk, steroidogenesis, adrenal gland, liver
- MeSH terms
- Adrenal Glands, Cholesterol, Cytochrome P-450 Enzyme System, Estradiol, Humans, Hydroxylation, Liver, Testosterone, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review